Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_assertion description "[The negative effects of cyclin G2 on cell cycle and cell proliferation, which occur without altering p27(Kip1) levels, may contribute to the ability of trastuzumab to inhibit breast cancer cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_assertion evidence source_evidence_literature NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_assertion SIO_000772 18025271 NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_assertion wasDerivedFrom befree-20140225 NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_assertion wasGeneratedBy ECO_0000203 NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP643157.RAvP3s1WLjVgUzBvooYJ4UG_jkcLKjbajS0Tq65zlMdvQ130_provenance.